• Ticker

    Advertisement
DJIA 12,801.23 -89.23 -0.69%
NASDAQ 2,903.88 -23.35 -0.80%
S&P 500 1,342.64 -9.31 -0.69%
Maintenance Notification

Quotes and Portfolios will be down on Sunday February 12, 2012 from 2 AM to 4 AM while we perform maintenance on the site. We apologize for the inconvenience.

$0.37 $0.04 (10.45%)

Quote as of 3:59 PM EST on 02/10/12

Hemispherx BioPharma, Inc.

AMEX:HEB

Jump to this page for:

Related Resources
HEB vs. S&P 500
$0.37 $0.04 (10.45%)
Today's Open $0.34
Previous Close $0.34
Daily Range $0.33 - $0.37
52-Week Range $0.17 - $0.57
Market Cap $50.16M
P/E Ratio -3.35
Dividend (Yield) $0.00 (0.0%)
Volume 737,775
Average Daily Volume 828,348
Current FY EPS -$0.08

HEB Information

Description
A biopharmaceutical company engaged in the clinical development, manufacture, marketing and distribution of new drug entities based on natural immune system enhancing technologies for the treatment of viral and immune based chronic disorders.
Sector
Healthcare
Industry
Biotechnology

Featured Real-Time
News & Commentary

HEB's Top Competitors

HEB

$0.37 (10.45%)

Current stock: HEB
AMGN

$67.36 (0.78%)

Current stock: AMGN
GILD

$53.75 (0.04%)

Current stock: GILD
BIIB

$118.14 (0.31%)

Current stock: BIIB